Concepedia

Comparator Selection

Comparator Selection is the systematic process of identifying and designating the appropriate healthcare intervention or standard of care against which a new health technology is evaluated in a budget impact analysis to ensure relevant and realistic financial forecasting.

30

Publications

1.5K

Citations

153

Authors

107

Institutions

Publications per year

2017–2026

13

Parents

Children

Publications

30

The Active Comparator, New User Study Design in Pharmacoepidemiology: Historical Foundations and Contemporary Application

Jennifer L. Lund, David B. Richardson, Til Stürmer‎ · Current Epidemiology Reports · 2015 · 691 citations · Full text

, , +9

Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators

Pharmacoepidemiology and Drug Safety · 2022 · 159 citations · Full text

, , +11

Inter-institution preference-based variability of ejection fraction and volumes using quantitative gated SPECT with 99mTc-tetrofosmin: a multicentre study involving 106 hospitals

Kenichi Nakajima, Tsunehiko Nishimura · European Journal of Nuclear Medicine and Molecular Imaging · 2005 · 63 citations · Full text

, , +2

Extending the Fellegi–Sunter probabilistic record linkage method for approximate field comparators

Scott L. DuVall, Richard A. Kerber, Alun Thomas · Journal of Biomedical Informatics · 2009 · 62 citations

, , +9

The importance and implications of comparator selection in pharmacoepidemiologic research

Monica D’Arcy, Til Stürmer‎, Jennifer L. Lund · Current Epidemiology Reports · 2018 · 58 citations

, , +8

1–5 of 30

Authors

153

  1. JL
    Jennifer L. Lund

    University of North Carolina at Chapel Hill, United States

    2 publications · 749 citations

    2

    h-index

  2. HG
    Hubert G. M. Leufkens

    Utrecht University, Netherlands

    2 publications · 45 citations

    2

    h-index

  3. TS
    Til Stürmer‎

    University of North Carolina at Chapel Hill, United States

    2 publications · 749 citations

    2

    h-index

  4. FP
    Frank Pétavy

    European Medicines Agency, Netherlands

    1 publications · 38 citations

    1

    h-index

  5. PK
    Peter K. Honig

    United States Food and Drug Administration, United States

    1 publications · 29 citations

    1

    h-index

1–5 of 153

Institutions

107

  1. Zorginstituut Nederland

    Diemen, The Netherlands

    3 h-index

    3 publications

    83 citations

  2. Odense University Hospital

    Odense, Denmark

    2 h-index

    10 publications

    364 citations

  3. National Institute for Health and Care Excellence

    Manchester, United Kingdom

    2 h-index

    4 publications

    106 citations

  4. Heinrich Heine University Düsseldorf

    Düsseldorf, Germany

    2 h-index

    2 publications

    75 citations

  5. University of North Carolina at Chapel Hill

    Chapel Hill, United States

    2 h-index

    6 publications

    2.2K citations

  6. Erasmus University Rotterdam

    Rotterdam, The Netherlands

    2 h-index

    2 publications

    34 citations

  7. University of Washington

    Seattle, United States

    2 h-index

    2 publications

    38 citations

  8. University of Southern Denmark

    Odense, Denmark

    2 h-index

    7 publications

    217 citations

1–8 of 107

Venues

  1. PharmacoEconomics

    2 publications · 50 citations

    2

    h-index

  2. Frontiers in Pharmacology

    2 publications · 38 citations

    2

    h-index

  3. Current Epidemiology Reports

    2 publications · 749 citations

    2

    h-index

  4. Health Economics Review

    2 publications · 40 citations

    2

    h-index

  5. Clinical Oncology

    1 publications · 12 citations

    1

    h-index

1–5